REQUEST A DEMO
Total
USD $0.00
Search more companies

Harbin Gloria Pharmaceuticals Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Harbin Gloria Pharmaceuticals Co., Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

HARBIN GLORIA PHARMACEUTICALS CO., LTD. focuses on developing orthopedic drugs, anti-tumor, antibiotic, nutritional drugs and its products include orthopedic drugs, rheumatic drugs, anticancer drugs, digestive system drugs, respiratory drugs, cardiovascular drugs, liver disease, medication, medicine, and gynecology antibiotics and other fields. The company has automatic production lines for drugs of 8 varieties including injections, frozen powder injection, lyophilized frozen powder injection, capsules, tablets, suppositories, powder injection filling and cancer drugs with national GMP certifications. Several of its products including “Songmeile”, one of Heilongjiang’s famous trademarks, have been listed in “China’s Catalogue for Basic Medical Insurance and Work Injury Insurance Drugs” and entitled the rights for individual pricing by State Development and Reformation Commission.

Headquarters
Building 28, Ronghui Garden, Yuhua Road, Area B, Airport Development Zone, Shunyi District, Beijing
Beijing; Beijing; Postal Code: 101318

Contact Details: Purchase the Harbin Gloria Pharmaceuticals Co., Ltd. report to view the information.

Website: http://www.gloria.cc

Basic Information
Total Employees:
Purchase the Harbin Gloria Pharmaceuticals Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Harbin Gloria Pharmaceuticals Co., Ltd. report to view the information.
Registered Capital:
Purchase the Harbin Gloria Pharmaceuticals Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Harbin Gloria Pharmaceuticals Co., Ltd. report to view the information.
Incorporation Date:
March 27, 2000
Key Executives
Purchase this report to view the information.
Supervisor
Purchase this report to view the information.
Supervisor
Ownership Details
Purchase this report to view the information.
4.84%
Purchase this report to view the information.
4.77%
Purchase this report to view the information.
2.76%
Purchase this report to view the information.
2.49%
Purchase this report to view the information.
1.88%
Subsidiaries
Anhui Boxin Enterprise Management Co., Ltd.
100%
Guangzhou Yudong Health Pharmaceutical Co., Ltd.
100%
Guangzhou Yudong Health Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Harbin Gloria Pharmaceuticals Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-9.48%
Total operating revenue
-12.69%
Operating profit (EBIT)
-14.63%
Net Profit (Loss) for the Period
-17%
Total assets
-20.57%
Total equity
3.04%
Operating Profit Margin (ROS)
-0.72%
Net Profit Margin
-0.94%
Return on Equity (ROE)
-2.42%
Debt to Equity Ratio
-40.83%
Quick Ratio
-0.01%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?